Cogni
Cogni (legally CogniCheck Inc.) is a Kitchener, Ontario-based brain health company that develops voice-based cognitive health tools for brain wellness monitoring and early detection of cognitive change, serving individual consumers, clinicians, researchers, and enterprise partners.
- Company typePrivate
- Founded2025
- HeadquartersKitchener, Canada
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What Cogni does
Cogni (legally CogniCheck Inc.) is a Kitchener, Ontario-based brain health company founded in 2025 that develops voice-based cognitive health tools for brain wellness monitoring and early detection of cognitive change. The company operates a voice-first cognitive health platform serving four segments: individual consumers seeking proactive cognitive monitoring, academic researchers and clinicians requiring scalable cognitive screening tools, healthcare providers and care teams managing cognitive wellness at population scale, and enterprise partners seeking to embed cognitive assessment into existing workflows. The company positions itself as a brain health lab applying voice biomarker research to real-world cognitive care tools.
The platform is built around three integrated products. Calista is the consumer-facing brain health companion, accessible via a simple phone call or iOS/Android app with no downloads or logins required, that engages users in natural conversations and delivers cognitive wellness insights and longitudinal trend tracking after each session. CogniClassifier is the proprietary machine learning engine that analyzes voice biomarkers from those conversations to detect and classify cognitive disorders including early-stage dementia. CogniDashboard is a command-center platform that gives healthcare providers, researchers, and care teams full visibility into user cognitive wellness, with capabilities for dispatching calls, tracking results, viewing trends, and exporting data. Underlying technical capabilities span speech and audio processing, natural language processing, and predictive analytics. The platform is HIPAA and PIPEDA compliant, supports multilingual interaction, and is built for accessibility.
Cogni operates a hybrid go-to-market. The Calista consumer product uses a product-led growth motion, with a monthly subscription revenue model distributed globally via phone and mobile app channels and supported by content marketing, a newsletter, and organic social media (Facebook, Instagram, LinkedIn, X). CogniClassifier and CogniDashboard are offered to researchers, clinicians, healthcare providers, and enterprise partners through an enterprise sales motion with direct inquiry forms and partnership agreements, with revenue generated through enterprise licensing. No pricing tiers are publicly disclosed. The company has also established a research partnership program with multiple unnamed collaborators in the brain health and voice biomarker space and received support from the Center of Aging and Brain Health Innovation.
Cogni firmographics
Firmographics- Name
- Cogni
- Legal name
- CogniCheck Inc.
- Website
- https://cogni.inc
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Cogni (legally CogniCheck Inc.) is a Kitchener, Ontario-based brain health company that develops voice-based cognitive health tools for brain wellness monitoring and early detection of cognitive change, serving individual consumers, clinicians, researchers, and enterprise partners.
- Ownership category
- akta.pro rank
Cogni industry classification
Industry- Product category
- Digital Cognitive Health Platform
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industries
- Behavioral Health & Substance Use Remote Monitoring (HLACAFAD), Cognitive Stimulation & Reminiscence Therapy (Non-Clinical) (HSABAEAH), Meditation Apps, Digital Courses & Online Communities (HSADAJAH)
Keywords
Where Cogni is headquartered
LocationHeadquarters
- HQ city
- Kitchener
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Cogni business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- Calista Consumer Subscription: Calista offers cognitive wellness monitoring via phone call or app for individual consumers. The platform tracks cognitive wellness over time through conversational interactions and provides insights after each call.
- Enterprise Licensing (CogniClassifier, CogniDashboard): CogniClassifier ML model and CogniDashboard platform are offered to enterprise partners, researchers, clinicians, and healthcare providers for integration into their cognitive screening workflows. Revenue likely generated through licensing agreements with enterprise clients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Consumer brain wellness via phone or app |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Cogni product offering
Product offeringCore offering
Cogni develops a voice-first cognitive health platform that turns voice biomarker research into tools for early detection and monitoring of cognitive decline. It sells three products: Calista, a consumer brain wellness companion delivered via phone call or mobile app that conducts natural conversations and provides cognitive wellness insights; CogniClassifier, a proprietary ML model that analyzes voice biomarkers to detect and classify cognitive disorders including early-stage dementia; and CogniDashboard, a command centre for healthcare providers, researchers, and care teams to dispatch calls, track results, view trends, and export cognitive wellness data at scale.
Product overview
Cogni is a brain health lab offering a voice-first cognitive health platform composed of three integrated products. Calista serves as the consumer-facing brain health companion delivered via phone calls, enabling users to monitor their cognitive wellness through natural conversations. CogniClassifier is the proprietary ML engine powering the technology, analyzing voice biomarkers to detect and classify cognitive disorders including early-stage dementia. CogniDashboard provides healthcare providers and care teams with a command center interface to manage cognitive care programs at scale. These three products work together as a unified platform: Calista captures voice data from end users, CogniClassifier processes and analyzes the voice biomarkers, and CogniDashboard enables healthcare organizations to deploy, monitor, and manage the cognitive screening workflow.
Differentiator
Problem solved
Functional benefit
Brands
- Calista: Consumer brain wellness companion, delivered by phone. A brain health companion that monitors cognitive wellness through voice biomarker analysis during natural phone conversations.
- CogniClassifier
- CogniDashboard
Products and services
- Calista
Quantifiable outcome
- Brain health monitoring accessible via phone call without downloads or logins
Companies that use Cogni
Customer profileSegments4 records
Ideal customer profiles4 records
Cogni technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature3 records
Cogni partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Research PartnerscoreCogni collaborates with multiple research partners in the brain health and voice biomarker space. The website indicates 0+ research partners and features a research partnership inquiry option. These partnerships support the company's mission of applying voice biomarker research into real-world cognitive health tools.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Cogni competitors and assessment
Company assessmentDirect peers
- Altoida: Altoida develops digital biomarkers (including voice and behavioral signals) for the early detection and assessment of Alzheimer's disease and other cognitive conditions. It is the most directly comparable competitor to Cogni's CogniClassifier, pursuing a similar ML-driven approach to cognitive health monitoring.
- Cambridge Cognition: Cambridge Cognition (including the acquired Winterlight Labs) provides computerized cognitive assessments and speech-based analysis tools for clinical trials, healthcare, and research. It directly overlaps with Cogni's enterprise offering for researchers and clinicians.
- Winterlight Labs: Winterlight Labs (acquired by Cambridge Cognition) develops speech-based cognitive assessment tools that analyze acoustic and linguistic features of speech to detect cognitive impairment. It is one of the closest pure-play voice biomarker cognitive competitors to Cogni.
- Linus Health: Linus Health offers a digital cognitive assessment platform that uses speech analysis and digital pen-and-paper tests to detect early signs of cognitive impairment and dementia. It directly competes with Cogni on voice-based cognitive screening for clinicians and health systems.
- Neurotrack: Neurotrack provides digital cognitive health screening and memory assessment tools focused on early detection of cognitive decline and Alzheimer's disease. It serves both consumers and clinicians, paralleling Cogni's dual GTM motion.
- Cogstate: Cogstate provides computerized cognitive tests and assessment services primarily for clinical trials, healthcare, and research organizations. Its enterprise-focused cognitive assessment suite overlaps with CogniClassifier and CogniDashboard's clinical/research positioning.
- Canary Speech: Canary Speech builds voice biomarker analysis technology using machine learning to detect and monitor health conditions including cognitive and mental health states. It uses the same underlying voice-biomarker approach as Cogni's CogniClassifier.
- Sonde Health: Sonde Health is a voice biomarker platform that analyzes vocal features to detect mental health and cognitive conditions. It targets enterprise health partners and is directly comparable to CogniClassifier and CogniDashboard's enterprise use cases.
- BrainCheck: BrainCheck offers a digital cognitive testing platform used by clinicians to assess and monitor cognitive function, including for dementia and concussion. It targets the same healthcare-provider and B2B segment that Cogni pursues with CogniDashboard.
Broad incumbents
- Headspace Health: Headspace Health operates a large-scale consumer mental wellness platform with subscription and B2B distribution, overlapping with Calista's consumer brain-wellness positioning. It does not compete on cognitive biomarker detection but is a comparable consumer mind-health destination.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Cogni social profiles
Digital presenceCogni compliance and trust
Trust signalCompliance2 records
Cogni financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cogni leadership team
Management profileNumber of profiles
Cogni funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cogni M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cogni
What does Cogni do?
Cogni develops a voice-first cognitive health platform that turns voice biomarker research into tools for early detection and monitoring of cognitive decline. It sells three products: Calista, a consumer brain wellness companion delivered via phone call or mobile app that conducts natural conversations and provides cognitive wellness insights; CogniClassifier, a proprietary ML model that analyzes voice biomarkers to detect and classify cognitive disorders including early-stage dementia; and CogniDashboard, a command centre for healthcare providers, researchers, and care teams to dispatch calls, track results, view trends, and export cognitive wellness data at scale.
Is Cogni a public or private company?
Cogni is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cogni founded?
Cogni was founded in 2025. It employs 1 to 10 people.
Where is Cogni based?
Cogni is headquartered in Kitchener, Canada, in the North America region.
How does Cogni make money?
Two revenue lines are on record. Calista Consumer Subscription is the primary driver. The others are enterprise Licensing (CogniClassifier, CogniDashboard).
Who are Cogni's main competitors?
Direct peers on record are Altoida, Cambridge Cognition, Winterlight Labs, Linus Health, Neurotrack, Cogstate, Canary Speech, Sonde Health and BrainCheck. Headspace Health is listed as a broad incumbent.
Does Cogni have an API?
No public API is recorded for Cogni.
What industry is Cogni in?
Cogni's product category is Digital Cognitive Health Platform. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLACAFAD, Behavioral Health & Substance Use Remote Monitoring. Its NAICS code is 518 and its SIC code is 7372.